Looking back at heart valve disease care across South Korea over 10 years
Reviews past heart ultrasound and medical records of people with moderate or severe valve disease.
Key facts
- Who runs it
- Yonsei University
- Where
- Seoul, South KoreaSee the 2 sites
- Trial code
- Registry title
- Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice
- Status
- Recruiting
- People taking part
- 30,000 people, planned
- Started
- 22 Sept 2025
- Expected to end
- 31 Dec 2027
- Type of study
- Observational, 3 groups
- Record updated
- 30 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with moderate or severe disease of their own heart valves. It looks back at records and heart ultrasound scans from 2010.1.1 to 2020.12.31.
- Age
- Older than 18 years (from 19 Years).
- Sex
- All sexes can join.
- Disease stage
- Moderate or severe disease of the person's own (native) heart valve: narrowing of the aortic valve (AS), leaking aortic valve (AR), leaking mitral valve (MR) or leaking tricuspid valve (TR).
- Earlier treatment
- People must have had a heart ultrasound (echocardiography) more than twice.
Main reasons for not taking part
- Poor quality heart ultrasound images
- Lost to follow-up
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Period: 2010.1.1~2020.12.31
- Age > 18 years
- Moderate or severe native VHD (AS, AR, MR and TR)
- Perform echocardiography more than twice
Who cannot take part
- Poor image of echocardiography
- Follow up loss
Where in South Korea
- Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of MedicineSeoul, South KoreaContact: Geu-Ru Hong, MD, PhDTaking people
- Yonsei University College of MedicineSeoul, South KoreaContact: Geu-Ru HongTaking people
About the trial
What the trial wants to find out
Valvular heart disease (VHD) is a growing public health concern globally, with increasing disease burden and rising interest in advanced treatment strategies such as transcatheter interventions. However, there remains a significant lack of real-world data regarding echocardiography practices, disease prevalence and progression, referral patterns, and treatment pathways. Addressing these gaps is critical for improving patient care and informing clinical decision-making.
Read full original descriptionShow less
South Korea provides a unique opportunity to conduct a nationwide retrospective echocardiographic study due to its advanced healthcare infrastructure, high patient volume, and strong tradition in clinical research. The current study aims to evaluate the real-world burden and clinical journey of patients with moderate or severe valvular disease over a 10-year period, based on echocardiographic and electronic medical record (EMR) data collected from multiple tertiary centers across the country.
The 3 groups in the trial
- Aortic petients
Primary focus is aortic stenosis patients; secondary focus is aortic regurgitation.
- Mitral Patients
Primary focus is Degenerative Mitral Regurgitation patients; secondary focus is Functional Mitral Regurgitation.
- Tricuspid Patients
Primary focus is Tircuspid Regurgitation patients
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice
- Plain-language title
- Looking back at heart valve disease care across South Korea over 10 yearsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 30 October 2026